AlphaCentric Advisors »

Ionis Pharmaceuticals shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.5M 19k 79.11
2024-12-31 $266k 7.6k 34.96

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Ionis Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Wellington Management Company
Bellevue Group
State Street Corporation
Deep Track Capital
Geode Capital Management
Citadel Advisors
Tweedy, Browne Company
Two Sigma Advisers
Deerfield Management Company
Summit Partners Public Asset Management

View all funds holding Ionis Pharmaceuticals